Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2023-2030
Triton’s report suggests that the Asia-Pacific cough syrup market is assessed to witness robust growth with a CAGR of 4.01% over the forecasting years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
studied region includes the following countries:
•
China
•
Japan
•
South Korea
•
India
•
Australia & New Zealand
•
ASEAN Countries
•
Rest of Asia-Pacific
Healthcare product and
pharmacy accessibility is on the rise across various Asia-Pacific nations. This
increased accessibility has led to the easy availability of cough syrups for
consumers. Furthermore, many countries are witnessing an increase in their aging
populations, leading to vulnerability to respiratory ailments among the
elderly, consequently driving up the demand for tailored cough syrups. However,
the introduction of novel cough syrup medications can face obstacles due to
stringent regulatory standards and approval processes.
China leads with the majority of the share in
the given market. The nation’s prominent role as a
major exporter of active pharmaceutical ingredients (API) has significantly
impacted the domestic cough syrup market. Leveraging its robust pharmaceutical
industry and API production capabilities, China provides essential components
for cough syrup and other pharmaceutical products on a global scale. This fuels
domestic cough syrup manufacturing and solidifies China’s reputation as a
dependable global supplier, creating opportunities for the cough syrup market.
The Japanese government’s
dedication to providing accessible and affordable healthcare significantly
boosts the demand for cough syrups. The nation boasts a strong national
healthcare policy, prioritizing the affordability and accessibility of
healthcare products, including medications. This commitment is realized through
active regulation of drug prices, promotion of generic medication usage, and
negotiations with pharmaceutical firms to manage healthcare expenses. As a
result, this strategy guarantees that cough syrups and other vital medications
remain affordable for the elderly and the general public. Hence, these factors
widen the overall scope of the cough syrup market.
Cough syrups are
commonly utilized by adults experiencing weakened immune systems due to the
natural aging process. This increased vulnerability to respiratory ailments,
such as the common cold, flu, or bronchitis, makes adults more prone to these
illnesses than children. Moreover, adults often encounter a greater array of
environmental factors that can trigger respiratory irritation and coughing.
This may result from exposure to various contaminants, allergens, and
occupational hazards. These factors collectively contribute to the heightened
susceptibility of adults to coughing-related issues. The market is broadly segmented into age group, distribution channel,
and product type. The age group is further sectioned into adults,
pediatric, and adolescents.
The
renowned companies in the market include The Himalaya Wellness Company, Acella
Pharmaceuticals LLC, Merck KGaA, Abbott Laboratories, Glenmark Pharmaceuticals
Limited, and Dabur India Ltd.
Himalaya Wellness, a contemporary Ayurvedic enterprise, offers an extensive range of wellness merchandise harnessing the advantages of herbs. With a global presence spanning more than 100 nations, the company offers a comprehensive selection of scientifically-researched herbal concoctions, USDA-certified organic individual herbs, and personal care items. Its corporate headquarters is situated in Bangalore, Karnataka, India.
KEY
DELIVERABLES OF THE REPORT:
·
Market CAGR during the forecasting years 2023-2030
·
Detailed data highlighting key insights, industry
components, and market strategies
·
Comprehensive information and estimation of the cough
syrup market revenue growth in the Asia-Pacific and its influence on the parent
market
·
In-depth study of forthcoming trends in consumer
behavioral patterns
·
A meticulous analysis of the competitive landscape,
vendor scorecard, and Porter’s Five Forces
·
A wide-ranging study of factors that will challenge
the APAC cough syrup market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
COUGH SYRUP MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE COUGH SYRUP MARKET
2.1.1. COVID-19
IMPACT
2.1.2. UKRAINE-RUSSIA
WAR IMPACT
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. INDUSTRY
COMPONENTS
2.3.1. RAW
MATERIALS
2.3.2. MANUFACTURERS
2.3.3. DISTRIBUTORS
2.3.4. RETAILERS
2.4. REGULATORY
FRAMEWORK
2.5. KEY
MARKET STRATEGIES
2.5.1. COLLABORATIONS
2.5.2. PRODUCT
LAUNCHES
2.5.3. ACQUISITIONS
2.5.4. BUSINESS
DIVESTITURES & EXPANSIONS
2.6. MARKET
DRIVERS
2.6.1. HIGH INCIDENCE OF
RESPIRATORY AILMENTS
2.6.2. VULNERABILITY
TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION
2.6.3. INNOVATIONS
IN COUGH SYRUPS
2.7. MARKET
CHALLENGES
2.7.1. OVERDOSE
RISKS ASSOCIATED WITH COUGH SYRUPS
2.7.2. STRICT
REGULATORY REQUIREMENTS
2.7.3. INCREASING
COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS
2.8. MARKET
OPPORTUNITIES
2.8.1. SELF-MEDICATION
TRENDS INCREASE DEMAND FOR OTC DRUGS
2.8.2. HERBAL COUGH SYRUPS EMERGE
AS A SAFER ALTERNATIVE
2.8.3. EASE
OF PURCHASE OFFERED BY E-COMMERCE CHANNELS
2.8.4. AVAILABILITY OF SUGAR-FREE
COUGH SYRUPS
2.8.5. GROWING
PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS
2.9. ANALYST
PERSPECTIVE
3. ASIA-PACIFIC
COUGH SYRUP MARKET – BY PRODUCT TYPE
3.1. COUGH
SUPPRESSANTS
3.2. COMBINATION
MEDICINES
3.3. EXPECTORANTS
4. ASIA-PACIFIC
COUGH SYRUP MARKET – BY AGE GROUP
4.1. ADULTS
4.2. ADOLESCENTS
4.3. PEDIATRIC
5. ASIA-PACIFIC
COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL
5.1. RETAIL
PHARMACIES
5.2. HOSPITAL
PHARMACIES
5.3. E-PHARMACIES
6. ASIA-PACIFIC
COUGH SYRUP MARKET – BY COUNTRY OUTLOOK
6.1. CHINA
6.1.1. CHINA
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2. JAPAN
6.2.1. JAPAN
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3. INDIA
6.3.1. INDIA
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.4. SOUTH
KOREA
6.4.1. SOUTH
KOREA COUGH SYRUP MARKET FORECAST & PROSPECTS
6.5. ASEAN
COUNTRIES
6.5.1. ASEAN
COUNTRIES COUGH SYRUP MARKET FORECAST & PROSPECTS
6.6. AUSTRALIA
& NEW ZEALAND
6.6.1. AUSTRALIA
& NEW ZEALAND COUGH SYRUP MARKET FORECAST & PROSPECTS
6.7. REST
OF ASIA-PACIFIC
6.7.1. REST
OF ASIA-PACIFIC COUGH SYRUP MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1. GSK
PLC
7.1.1. OVERVIEW
7.1.2. PRODUCT
PORTFOLIO
7.1.3. KEY
STRENGTHS
7.1.4. KEY
CHALLENGES
7.2. PFIZER
INC
7.2.1. OVERVIEW
7.2.2. PRODUCT
PORTFOLIO
7.2.3. KEY
STRENGTHS
7.2.4. KEY
CHALLENGES
7.3. NOVARTIS
AG
7.3.1. OVERVIEW
7.3.2. PRODUCT
PORTFOLIO
7.3.3. KEY
STRENGTHS
7.3.4. KEY
CHALLENGES
7.4. RECKITT
BENCKISER GROUP PLC
7.4.1. OVERVIEW
7.4.2. PRODUCT
PORTFOLIO
7.4.3. KEY
STRENGTHS
7.4.4. KEY
CHALLENGES
7.5. THE PROCTER
& GAMBLE COMPANY
7.5.1. OVERVIEW
7.5.2. PRODUCT
PORTFOLIO
7.5.3. KEY
STRENGTHS
7.5.4. KEY
CHALLENGES
7.6. SANOFI
SA
7.6.1. OVERVIEW
7.6.2. PRODUCT
PORTFOLIO
7.6.3. KEY
STRENGTHS
7.6.4. KEY
CHALLENGES
7.7. CIPLA LIMITED
7.7.1. OVERVIEW
7.7.2. PRODUCT
PORTFOLIO
7.7.3. KEY STRENGTHS
7.7.4. KEY
CHALLENGES
7.8. KENVUE
INC
7.8.1. OVERVIEW
7.8.2. PRODUCT
PORTFOLIO
7.8.3. KEY
STRENGTHS
7.8.4. KEY
CHALLENGES
7.9. ASTRAZENECA
PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT
PORTFOLIO
7.9.3. KEY
STRENGTHS
7.9.4. KEY
CHALLENGES
7.10. ACELLA
PHARMACEUTICALS LLC
7.10.1. OVERVIEW
7.10.2. PRODUCT
PORTFOLIO
7.10.3. KEY
STRENGTHS
7.10.4. KEY
CHALLENGES
7.11. THE
HIMALAYA WELLNESS COMPANY
7.11.1. OVERVIEW
7.11.2. PRODUCT
PORTFOLIO
7.11.3. KEY
STRENGTHS
7.11.4. KEY
CHALLENGES
7.12. MERCK
KGAA
7.12.1. OVERVIEW
7.12.2. PRODUCT
PORTFOLIO
7.12.3. KEY
STRENGTHS
7.12.4. KEY
CHALLENGES
7.13. ABBOTT
LABORATORIES
7.13.1. OVERVIEW
7.13.2. PRODUCT
PORTFOLIO
7.13.3. KEY
STRENGTHS
7.13.4. KEY
CHALLENGES
7.14. GLENMARK
PHARMACEUTICALS LIMITED
7.14.1. OVERVIEW
7.14.2. PRODUCT
PORTFOLIO
7.14.3. KEY
STRENGTHS
7.14.4. KEY
CHALLENGES
7.15. DABUR
INDIA LTD
7.15.1. OVERVIEW
7.15.2. PRODUCT
PORTFOLIO
7.15.3. KEY
STRENGTHS
7.15.4. KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF BUSINESS
DIVESTITURES & EXPANSIONS
TABLE 7: ASIA-PACIFIC COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC COUGH
SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 10:
ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: INDUSTRY COMPONENTS
FIGURE 2: ASIA-PACIFIC COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE 3: ASIA-PACIFIC COUGH
SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC COUGH
SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC COUGH
SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)
FIGURE 6: ASIA-PACIFIC COUGH
SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC COUGH
SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC COUGH
SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)
FIGURE 10: ASIA-PACIFIC COUGH
SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC COUGH
SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC COUGH
SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 14: CHINA COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 15: JAPAN COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 16: INDIA COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: SOUTH KOREA COUGH
SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: ASEAN COUNTRIES
COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: AUSTRALIA & NEW
ZEALAND COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: REST OF
ASIA-PACIFIC COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)